Akzo Nobel Management
Management criteria checks 2/4
Akzo Nobel's CEO is Greg Poux-Guillaume, appointed in Nov 2022, has a tenure of 2.08 years. total yearly compensation is €4.93M, comprised of 24.8% salary and 75.2% bonuses, including company stock and options. directly owns 0.004% of the company’s shares, worth €410.60K. The average tenure of the management team and the board of directors is 6.2 years and 2.7 years respectively.
Key information
Greg Poux-Guillaume
Chief executive officer
€4.9m
Total compensation
CEO salary percentage | 24.8% |
CEO tenure | 2.1yrs |
CEO ownership | 0.004% |
Management average tenure | 6.2yrs |
Board average tenure | 2.7yrs |
Recent management updates
Recent updates
Why Akzo Nobel N.V. (AMS:AKZA) Could Be Worth Watching
Nov 25Is Akzo Nobel (AMS:AKZA) A Risky Investment?
Oct 14Why We're Not Concerned About Akzo Nobel N.V.'s (AMS:AKZA) Share Price
Oct 01Akzo Nobel's (AMS:AKZA) Returns On Capital Are Heading Higher
Sep 17What Is Akzo Nobel N.V.'s (AMS:AKZA) Share Price Doing?
Aug 21Akzo Nobel N.V. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Jul 26We Think Akzo Nobel (AMS:AKZA) Can Stay On Top Of Its Debt
Jul 03Akzo Nobel N.V. (AMS:AKZA) Shares Could Be 28% Below Their Intrinsic Value Estimate
Jun 20Akzo Nobel (AMS:AKZA) Is Doing The Right Things To Multiply Its Share Price
Jun 06Market Cool On Akzo Nobel N.V.'s (AMS:AKZA) Earnings
May 10Should You Investigate Akzo Nobel N.V. (AMS:AKZA) At €66.58?
Mar 25We Think Akzo Nobel (AMS:AKZA) Can Stay On Top Of Its Debt
Mar 10Akzo Nobel (AMS:AKZA) Is Doing The Right Things To Multiply Its Share Price
Feb 23Is There An Opportunity With Akzo Nobel N.V.'s (AMS:AKZA) 44% Undervaluation?
Jan 24When Should You Buy Akzo Nobel N.V. (AMS:AKZA)?
Dec 13These 4 Measures Indicate That Akzo Nobel (AMS:AKZA) Is Using Debt Reasonably Well
Nov 02Akzo Nobel N.V.'s (AMS:AKZA) Intrinsic Value Is Potentially 94% Above Its Share Price
Oct 04Why Akzo Nobel N.V. (AMS:AKZA) Could Be Worth Watching
Sep 04Akzo Nobel's (AMS:AKZA) Returns On Capital Are Heading Higher
Aug 07Is Akzo Nobel (AMS:AKZA) A Risky Investment?
Jul 24Akzo Nobel N.V. (AMS:AKZA) Shares Could Be 36% Below Their Intrinsic Value Estimate
Jun 28Is Akzo Nobel N.V. (AMS:AKZA) Potentially Undervalued?
May 31Returns On Capital At Akzo Nobel (AMS:AKZA) Have Hit The Brakes
Apr 28We Think Akzo Nobel (AMS:AKZA) Is Taking Some Risk With Its Debt
Feb 26At €68.92, Is It Time To Put Akzo Nobel N.V. (AMS:AKZA) On Your Watch List?
Feb 12Is Akzo Nobel N.V. (AMS:AKZA) Trading At A 26% Discount?
Jan 16These 4 Measures Indicate That Akzo Nobel (AMS:AKZA) Is Using Debt Extensively
Nov 22Is It Time To Consider Buying Akzo Nobel N.V. (AMS:AKZA)?
Nov 06Akzo Nobel N.V.'s (AMS:AKZA) Intrinsic Value Is Potentially 91% Above Its Share Price
Oct 12Is Akzo Nobel (AMS:AKZA) Using Too Much Debt?
Aug 12Why Akzo Nobel's (AMS:AKZA) Shaky Earnings Are Just The Beginning Of Its Problems
Jul 28Is There Now An Opportunity In Akzo Nobel N.V. (AMS:AKZA)?
Jul 10Akzo Nobel (AMS:AKZA) Has A Pretty Healthy Balance Sheet
May 11Akzo Nobel (AMS:AKZA) Will Pay A Larger Dividend Than Last Year At €1.54
Apr 15At €78.10, Is Akzo Nobel N.V. (AMS:AKZA) Worth Looking At Closely?
Apr 10Akzo Nobel (AMS:AKZA) Is Increasing Its Dividend To €1.54
Mar 27Is There An Opportunity With Akzo Nobel N.V.'s (AMS:AKZA) 47% Undervaluation?
Mar 22Akzo Nobel's (AMS:AKZA) Shareholders Will Receive A Bigger Dividend Than Last Year
Mar 06Akzo Nobel (AMS:AKZA) Is Paying Out A Larger Dividend Than Last Year
Feb 20Here's Why We Think Akzo Nobel (AMS:AKZA) Is Well Worth Watching
Jan 13Is Akzo Nobel (AMS:AKZA) A Risky Investment?
Jan 02Are Investors Undervaluing Akzo Nobel N.V. (AMS:AKZA) By 38%?
Dec 20CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2024 | n/a | n/a | €565m |
Jun 30 2024 | n/a | n/a | €592m |
Mar 31 2024 | n/a | n/a | €534m |
Dec 31 2023 | €5m | €1m | €447m |
Sep 30 2023 | n/a | n/a | €411m |
Jun 30 2023 | n/a | n/a | €309m |
Mar 31 2023 | n/a | n/a | €303m |
Dec 31 2022 | €2m | €204k | €362m |
Compensation vs Market: Greg's total compensation ($USD5.17M) is about average for companies of similar size in the Dutch market ($USD4.34M).
Compensation vs Earnings: Greg's compensation has increased by more than 20% in the past year.
CEO
Greg Poux-Guillaume (54 yo)
2.1yrs
Tenure
€4,934,990
Compensation
Mr. Grégoire Poux-Guillaume, also known as Greg, was Chairman of the Board at medmix AG since September 20, 2021 and continues to served as its Director since 2024. He had been the Chief Executive Officer...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Chairman of the Management Board | 2.1yrs | €4.93m | 0.0042% € 410.6k | |
CFO & Member of Management Board | 6.9yrs | €2.77m | 0.014% € 1.3m | |
Chief Technology Officer | no data | no data | no data | |
Head Of Investor Relations | no data | no data | no data | |
General Counsel | less than a year | no data | no data | |
Global Head of Communications & Public Affairs and Corporate Director | 9.5yrs | no data | no data | |
Chief Human Resources Officer | 1.4yrs | no data | no data | |
Chief Financial Officer of Specialty Chemicals Business | 6.8yrs | no data | no data | |
CEO of Specialty Chemicals | 6.2yrs | no data | no data | |
Chief Integrated Supply Chain Officer | 3.3yrs | no data | no data | |
Group Treasurer | 8.9yrs | no data | no data | |
Corporate Secretary | no data | no data | no data |
6.2yrs
Average Tenure
58yo
Average Age
Experienced Management: AKZA's management team is seasoned and experienced (6.2 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Independent Supervisory Board Chairman | 1.7yrs | €109.29k | 0.0014% € 132.6k | |
Independent Deputy Chairman of the Supervisory Board | 10.7yrs | €133.00k | 0.0019% € 189.6k | |
Independent Member of the Supervisory Board | 7.1yrs | €112.50k | no data | |
Independent Member of Supervisory Board | 2.7yrs | €107.50k | no data | |
Independent Member of the Supervisory Board | 9.9yrs | €100.00k | no data | |
Member of Supervisory Board | less than a year | no data | no data | |
Member of Supervisory Board | less than a year | no data | no data | |
Member of the Supervisory Board | less than a year | no data | no data | |
Independent Member of Supervisory Board | 2.7yrs | €110.00k | no data |
2.7yrs
Average Tenure
63yo
Average Age
Experienced Board: AKZA's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.